However this has not been tested in tumor models, it is plausible that SLURP1 can contribute to pancreatic cancer’s immunosuppressive tumor microenvironment and suppress anti-tumor immune responses. This evidence concerns the gene SLURP1 and familial pancreatic carcinoma.